Effective September 22, 2019, PathGroup will discontinue the Liver Fibrosis, Chronic Viral Hepatitis test (Test Code: FIBROM) and will replace it with the Liver Fibrosis, Fibro Test-ActiTest Panel (Test Code: FIBRO).
Click here for more information.
Search Results for
Specimen Requirement Changes: 12.08.2019
Effective December 8, 2019, several test codes will have changes to specimen containers and/or transportation temperatures.
Click here for more information.
Specimen Requirement Changes: 11.17.2019
Effective November 17, 2019, several test codes will have changes to specimen containers and/or transportation temperatures.
Click here for more information.
Specimen Requirement Changes: 10.20.2019
Effective October 20, 2019, several test codes will have changes to specimen containers and/or transportation temperatures.
Click here for more information.
Specimen Requirement Changes: 10.6.2019
Effective October 6, 2019, several test codes will have changes to specimen containers and/or transportation temperatures.
Click here for more information.
Specimen Requirement Changes: 9.22.2019
Effective September 22, 2019, several test codes will have changes to specimen containers and/or transportation temperatures.
Click here for more information.
Specimen Requirement Changes: 9.16.2019
Several test codes have had recent changes to specimen container and/or specimen transportation temperatures.
Click here for more information.
Test Update: Transition of RT3R to T3 Uptake
PathGroup has discontinued the Resin T3 Uptake Ratio test (Test Code: RT3R) and has replaced it with the T3 Uptake test (Test Code: T3U).
Click here for more information.
ICD Update: Cigna Coverage of Vitamin D Testing
Effective August 19, 2019, Cigna has updated its Vitamin D Testing Medical Coverage Policy (Coverage Policy Number 0526). The updated policy addresses medical necessity and associated ICD-10 codes for serum Vitamin D testing.
Click here for more information.
Test Announcement: SARS-CoV-2 (COVID-19) IgG Antibody Testing
Effective April 27, 2020, PathGroup is pleased to announce the availability of serologic testing for SARS-CoV-2, the pathogen associated with COVID-19. This new test is for the detection of human IgG antibodies against SARS-CoV-2 in serum or plasma.
To read more, click here.